Page last updated: 2024-10-31

mirtazapine and Dyslipidemia

mirtazapine has been researched along with Dyslipidemia in 3 studies

Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.

Research Excerpts

ExcerptRelevanceReference
"Treatment with mirtazapine, a widely prescribed antidepressant, has been linked to weight gain and dyslipidemia."4.31Weight-gain independent effect of mirtazapine on fasting plasma lipids in healthy men. ( Dose, T; Fulda, S; Heel, S; Hennings, JM; Holsboer, F; Kloiber, S; Lechner, K; Lucae, S; Schaaf, L; Uhr, M, 2023)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Lechner, K1
Heel, S1
Uhr, M1
Dose, T1
Holsboer, F1
Lucae, S1
Schaaf, L1
Fulda, S1
Kloiber, S1
Hennings, JM1
Song, HR1
Woo, YS1
Wang, HR1
Shim, IH1
Jun, TY1
Bahk, WM1
Moffatt, A1
Ticehurst, S1

Other Studies

3 other studies available for mirtazapine and Dyslipidemia

ArticleYear
Weight-gain independent effect of mirtazapine on fasting plasma lipids in healthy men.
    Naunyn-Schmiedeberg's archives of pharmacology, 2023, Volume: 396, Issue:9

    Topics: Antidepressive Agents; Cholesterol, HDL; Dyslipidemias; Fasting; Humans; Male; Mirtazapine; Triglyce

2023
Does mirtazapine interfere with naturalistic diabetes treatment?
    Journal of clinical psychopharmacology, 2014, Volume: 34, Issue:5

    Topics: Antidepressive Agents, Tricyclic; Blood Glucose; Body Mass Index; Case-Control Studies; Cholesterol;

2014
Mirtazapine-induced massive dyslipidaemia in an elderly woman.
    The Australian and New Zealand journal of psychiatry, 2013, Volume: 47, Issue:6

    Topics: Aged; Antidepressive Agents, Tricyclic; Dyslipidemias; Female; Humans; Mianserin; Mirtazapine

2013